BioAdaptives, Inc. (OTCMKTS: BDPT) has announced the commercial launch of MyndMed(TM), a next-generation dietary supplement aimed at improving memory, focus, and overall brain performance. The company reported that the product underwent extensive testing and received highly positive user feedback, leading to plans for scaling production and expanding distribution to meet anticipated high demand beginning in November.
Formulated to support cognitive function across short-, mid-, and long-term pathways, MyndMed(TM) is described by the company as offering "Mental Armor for Modern Minds(TM)." The supplement contains clinically studied ingredients that promote alertness, neuroplasticity, and cellular energy balance. Manufactured in the United States in cGMP-certified facilities, MyndMed(TM) is third-party tested for purity and is available nationwide at www.MyndMed.com.
The launch comes as part of BioAdaptives' broader strategy through its ClearMynd division to develop and market products that advance cognitive performance, recovery, and enduring brain health. The company positions itself as a pioneer in science-driven health and wellness formulations, focusing on empowering performance and accelerating recovery.
This announcement highlights the growing demand for cognitive-support supplements, particularly as consumers increasingly seek non-pharmaceutical solutions to enhance mental performance. The positive early feedback and planned production scale-up indicate strong market interest, which could position BioAdaptives favorably in the competitive dietary supplement industry.
For more information about BioAdaptives and its product line, visit the company's website at www.bioadaptives.com. The full press release detailing the launch is available at https://nnw.fm/Lehwp.
